Skip to main content
Log in

The influence of subtotal thyroidectomy on the thyroglobulin binding capacity of thyrotoxic serum

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

It has been shown previously that large amounts of thyroglobulin are released into the circulation by the trauma of thyroid surgery. In order to characterize the response to this challenge in patients with and without autoimmune disease, serial estimations of thyroglobulin binding capacity (AgBC) using a sensitive double antibody technique were made on 105 patients undergoing partial thryroidectomy for thyrotoxicosis (70 patients prepared medically) and nontoxic goiter (35 patients). Samples were measured the day before, the day of, and on eight subsequent occasions during the first 14 days after surgery. Three distinct patterns of change in AgBC were observed in the thyrotoxic patients: i) when elevated before surgery, it fell acutely within 48 h of operation and rose again within the first 7–10 days (8 patients); ii) it rose briskly, though transiently, when low (< 10%) before surgery (4 patients); iii) when elevated before surgery, it rose or fell gently afterwards without sudden change (7 patients). The AgBC in 51 of the Graves’ disease patients never exceeded 10% during the perioperative period, and was immeasurably low in all nontoxic goiter patients. Autoimmune thyroid disease results from a disturbance of normal tolerance to thyroid antigens, and thyroid surgery provides an in vivo model in which the response to an acute antigenic challenge may be studied. Patients with Graves’ disease showed varying degrees of intolerance to the challenge, while those with nontoxic goiter and no evidence of autoimmune disease were uniformly unresponsive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hjort T., Pedersen G. Thyroid antibodies and thyroglobulin in the serum. Lancet 1: 259, 1962.

    Article  Google Scholar 

  2. Assem E.S.K. Thyroglobulin in the serum of parturient women and newborn infants. Lancet 1:139, 1964.

    Article  CAS  PubMed  Google Scholar 

  3. Roitt I.M., Torrigiani G. Identification and estimation of undergraded thyroglobulin in human serum. Endocrinology 81: 421, 1967.

    Article  CAS  PubMed  Google Scholar 

  4. Van Herle A.J., Uller R.P., Matthews N.L., Brown J. Radioimmunoassay for measurement of thyroglobulin in human serum. J. Clin. Invest. 52:1320, 1973.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Bankhurst A.D., Torrigiani G., Allison A.C. Lymphocytes which bind thyroglobulin in healthy people and its relevance to tolerance for auto-antigens. Lancet 1: 226, 1973.

    Article  CAS  PubMed  Google Scholar 

  6. Aldo-Benson M., Borel Y. The tolerant cell: direct evidence for receptor blockade by tolerogen. J. Immunol. 112:1793, 1974.

    CAS  PubMed  Google Scholar 

  7. Weigle W.O. The immune response of rabbits tolerant to bovine serum albumin. J. Exp. Med. 144:111, 1961.

    Article  Google Scholar 

  8. Lerman J. Iodine components of the blood. Circulating thyroglobulin in normal persons and in persons with thyroid disease. J. Clin. Invest. 19:555, 1940.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Hjort T. Determination of serum thyroglobulin by a haemagglutination test. Lancet 1:1262, 1961.

    Article  CAS  PubMed  Google Scholar 

  10. Torrigiani G. Immunological responses to thyroglobulin. Ph. D. Thesis, University of London, 1965.

    Google Scholar 

  11. Uller R.P., Van Herle A.J. Effect of therapy on serum thyroglobulin levels in patients with Graves’ disease. J. Clin. Endocrinol. Metab. 46: 747, 1978.

    Article  CAS  PubMed  Google Scholar 

  12. Wilkin T.J., Swanson Beck J., Hayes P.C., Potts R.C., Young R.J. A passive haemagglutination (TRC) inhibitor in thyrotoxic serum. Clin. Endocrinol. (Oxf.) 10: 507, 1979.

    Article  CAS  Google Scholar 

  13. Mitchison N.A. Dosage requirements for paralysis by soluble proteins. Immunology 15: 509, 1968.

    CAS  PubMed Central  PubMed  Google Scholar 

  14. Chiller J., Habicht G., Weigle W.O. Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science 171: 813, 1971.

    Article  CAS  PubMed  Google Scholar 

  15. Fulthorpe A.J., Roitt I.M., Doniach D., Couchman K. A stable sheep-cell preparation for detecting thyroglobulin antibodies, and its clinical applications. J. Clin. Pathol. 14:654, 1961.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Bayer M.F., Kriss J.P. A solid phase, sandwich-type radioimmunoassay for antithyroglobulin: elimination of false positive results and semiquantitative measurement of antithyroglobulin in the presence of elevated thyroglobulin. J. Clin. Endocrinol. Metab. 49: 565, 1979.

    Article  CAS  PubMed  Google Scholar 

  17. Burnet F.M., Freeman M. Process of formol detoxication: experiments with purified staphylococcal toxin. J. Pathol. Bact. 35: 477, 1932.

    Article  CAS  Google Scholar 

  18. Van Herle A.J., Uller R.P. Elevated serum thyroglobulin: a marker of metastases in differentiated thyroid carcinomas. J. Clin. Invest. 56:272, 1975.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Roitt I.M., Doniach D. Human autoimmune thyroiditis: serological studies. Lancet 2:1027, 1958.

    Article  CAS  PubMed  Google Scholar 

  20. Wilkin T.J., Swanson Beck J., Crooks J., Isles T.E., Gunn A. Time and tides in Graves’ disease. Their implications in predicting the outcome of treatment. Br. Med. J. 1:88, 1979.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Wilkin T.J., Swanson Beck J., Gunn A., Al Moussah M., Isles T.E., Crooks J. Autoantibodies in thyrotoxicosis: a quantitative study of their behaviour in relation to the course and outcome of treatment. J. Endocrinol. Invest. 3: 5, 1980.

    CAS  PubMed  Google Scholar 

  22. Wilkin T.J., Beck J.S., Hayes P.C., Gunn A., Al Moussah M., Crooks J., Potts R. The serial behaviour and significance of thyroglobulin antibody during the treatment of Graves’ disease, comparing haemagglutination with double antibody precipitation techniques. In: Pinchera A., Doniach D., Fenzi G.F., Baschieri L. (Eds.), Autoimmune aspects of endocrine disorders. Academic Press, New York, 1980, p. 185.

    Google Scholar 

  23. Pinchera A., Liberti P., Martino E., Fenzi G.F., Grasso L., Rovis L., Baschieri L. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J. Clin. Endocrinol. Metab. 29: 231, 1969.

    Article  CAS  PubMed  Google Scholar 

  24. Chiovato L., Macchia E., Mariotti S., Vitti P., Fenzi G.F., Pinchera A. Thyroid antibody levels during antithyroid drug therapy for Graves’ disease. Ann. Endocrinol. (Paris) 39: 21 A, 1978 (Abstract).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilkin, T.J., Swanson Beck, J., Gunn, A. et al. The influence of subtotal thyroidectomy on the thyroglobulin binding capacity of thyrotoxic serum. J Endocrinol Invest 3, 389–393 (1980). https://doi.org/10.1007/BF03349376

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349376

Key-words

Navigation